How Anesthetic, Analgesic and Other Non-Surgical Techniques During Cancer Surgery Might Affect Postoperative Oncologic Outcomes: A Summary of Current State of Evidence.
Patrice ForgetJose A AguirreIvanka BencicAlain BorgeatAllessandro CamaClaire M CondronChristina EintreiPilar ErolesAnil GuptaTim G HalesDaniela IonescuMark Zachary JohnsonPawel KabataIva KiracDaqing MaZhirajr MokiniJose Luis Guerrero OrriachMichael RetskySergio SandrucciWiebke SiekmannLjilja ŠtefančićGina Votta-VellisCara ConnollyDonal BuggyPublished in: Cancers (2019)
The question of whether anesthetic, analgesic or other perioperative intervention during cancer resection surgery might influence long-term oncologic outcomes has generated much attention over the past 13 years. A wealth of experimental and observational clinical data have been published, but the results of prospective, randomized clinical trials are awaited. The European Union supports a pan-European network of researchers, clinicians and industry partners engaged in this question (COST Action 15204: Euro-Periscope). In this narrative review, members of the Euro-Periscope network briefly summarize the current state of evidence pertaining to the potential effects of the most commonly deployed anesthetic and analgesic techniques and other non-surgical interventions during cancer resection surgery on tumor recurrence or metastasis.
Keyphrases
- papillary thyroid
- minimally invasive
- coronary artery bypass
- squamous cell
- patients undergoing
- neuropathic pain
- randomized controlled trial
- lymph node metastasis
- physical activity
- robot assisted
- type diabetes
- squamous cell carcinoma
- childhood cancer
- surgical site infection
- working memory
- young adults
- cardiac surgery
- machine learning
- big data
- cross sectional